What initial insulin glargine dose, insulin sensitivity factor, and carbohydrate‑to‑insulin ratio should be used for a 23‑year‑old obese male with type 2 diabetes (A1c 13 %), metabolic syndrome, mild metabolic acidosis, low‑grade ketosis, on metformin 2000 mg daily, admitted for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dosing for Hospitalized Type 2 Diabetes with Ketosis and Severe Hyperglycemia

Start insulin glargine (Lantus) at 0.5 units/kg/day (approximately 61 units once daily at bedtime for this 122 kg patient), use an insulin sensitivity factor (correction factor) of 1:30 initially (1 unit lowers glucose by 30 mg/dL), and begin with a carbohydrate ratio of 1:10 (1 unit per 10 grams of carbohydrate). 1, 2, 3

Immediate Assessment and Stabilization

This patient presents with mild diabetic ketoacidosis (DKA) based on bicarbonate 17 mEq/L (below the 18 mEq/L threshold), anion gap 16, and ketones 1.28, though the exact glucose level is not provided. 4, 2

Critical First Steps

  • Verify renal function before continuing metformin – metformin must be held if eGFR <30 mL/min/1.73 m² and is contraindicated during acute illness with risk of lactic acidosis, particularly with cellulitis and potential sepsis. 2, 5, 6

  • Check venous pH immediately – if pH <7.3, this patient requires IV insulin infusion at 0.1 units/kg/hour (approximately 12 units/hour) until resolution of acidosis (pH >7.3, bicarbonate >18 mEq/L, anion gap <12). 4, 3

  • Assess hydration status and initiate fluid resuscitation with isotonic saline while monitoring electrolytes every 2-4 hours, particularly potassium. 4, 3

Basal Insulin Dosing (Lantus)

For this 122 kg patient with A1c 13% and mild ketosis, initiate insulin glargine at 0.5 units/kg/day = 61 units once daily at bedtime. 1, 2, 3

Rationale for Higher Dosing

  • The American Diabetes Association recommends 0.5 units/kg/day (not the lower 0.1-0.2 units/kg/day) for patients with A1c ≥8.5% and marked hyperglycemia, which clearly applies here with A1c 13%. 2, 3

  • Obesity (BMI 41) and severe insulin resistance in metabolic syndrome require higher initial doses to overcome glucose toxicity. 1

  • This patient likely has prolonged poor glycemic control given the severely elevated A1c, necessitating aggressive initial therapy. 1, 3

Titration Protocol

  • Increase basal insulin by 2-4 units every 3 days based on fasting blood glucose, targeting fasting glucose 80-130 mg/dL. 3

  • Continue metformin 2000 mg daily once acidosis resolves and renal function is confirmed adequate (eGFR ≥30 mL/min/1.73 m²). 1, 2

Correction Scale (Insulin Sensitivity Factor)

Use an initial correction factor of 1:30 – meaning 1 unit of rapid-acting insulin (aspart, lispro, or glulisine) will lower blood glucose by approximately 30 mg/dL. 3

Calculation Method

  • The "1800 rule" for type 2 diabetes: 1800 ÷ total daily insulin dose = correction factor. 3

  • With estimated total daily dose of 61 units basal (will need prandial insulin added), initial correction factor = 1800 ÷ 61 ≈ 1:30. 3

Correction Scale Example

  • Blood glucose 151-200 mg/dL: Give 2 units rapid-acting insulin
  • Blood glucose 201-250 mg/dL: Give 3 units rapid-acting insulin
  • Blood glucose 251-300 mg/dL: Give 5 units rapid-acting insulin
  • Blood glucose 301-350 mg/dL: Give 7 units rapid-acting insulin
  • Blood glucose >350 mg/dL: Give 9 units and notify physician 3

Critical pitfall: Never use correction insulin alone without basal coverage – sliding scale monotherapy leads to poor outcomes and increased complications. 3

Carbohydrate Ratio

Start with a carbohydrate-to-insulin ratio of 1:10 – meaning 1 unit of rapid-acting insulin covers 10 grams of carbohydrate. 3

Prandial Insulin Requirements

  • This patient requires basal-bolus therapy, not basal insulin alone, given the severity of hyperglycemia (A1c 13%). 3

  • Calculate prandial insulin as 50% of total daily dose divided among three meals: If total daily dose is 61 units basal, add approximately 61 units prandial = 122 units total daily dose, with roughly 20 units rapid-acting insulin before each meal. 3

  • Adjust prandial insulin by 1-2 units every 3 days based on 2-hour postprandial glucose readings, targeting postprandial glucose <180 mg/dL. 3

Carbohydrate Ratio Calculation

  • The "500 rule": 500 ÷ total daily insulin dose = grams of carbohydrate covered by 1 unit. 3

  • With total daily dose of approximately 122 units: 500 ÷ 122 ≈ 1:4, but start more conservatively at 1:10 to avoid hypoglycemia and titrate based on response. 3

Monitoring Requirements During Hospitalization

  • Check blood glucose at least 4 times daily – before each meal and at bedtime, plus additional checks if symptomatic. 3

  • Monitor serum electrolytes, glucose, BUN, creatinine, and venous pH every 2-4 hours until acidosis resolves (bicarbonate >18 mEq/L, anion gap <12). 4, 3

  • Potassium replacement is critical – add 20-30 mEq potassium (2/3 KCl and 1/3 KPO4) to each liter of IV fluid once serum potassium falls below 5.5 mEq/L, assuming adequate urine output. 4

Transition and Long-Term Management

  • Once glucose control is achieved and acidosis resolves, attempt to taper insulin by decreasing the dose 10-30% every few days while maintaining metformin 2000 mg daily. 1, 2

  • Recheck A1c in 3 months – if A1c remains ≥7% despite maximum metformin, add a GLP-1 receptor agonist or SGLT2 inhibitor before further intensifying insulin. 1, 2

  • Many patients with type 2 diabetes can transition off insulin to oral agents alone once glucotoxicity resolves, though this patient's severe presentation may require long-term insulin therapy. 1

Common Pitfall to Avoid

Do not restart metformin until the cellulitis is resolving and metabolic acidosis has completely cleared – the combination of infection, acidosis, and metformin significantly increases lactic acidosis risk. 2, 5, 6

References

Guideline

Management of New-Onset Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Metformin Dosing for New Diabetes with High A1c Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Severe Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Does initiating SGLT2 (Sodium-Glucose Linked Transporter 2) inhibitors in patients with low C-peptide levels increase the risk of euglycemic ketoacidosis?
Can Farxiga (dapagliflozin) cause pancreatitis?
When to suspend dapagliflozina (dapagliflozin) in patients with type 1 or type 2 diabetes, particularly those with impaired renal function, heart failure, or at risk of diabetic ketoacidosis?
What are the precautions for using Dapagliflozin (Forxiga) in patients with a history of pancreatitis or at risk for pancreatitis?
What is the most appropriate long-term glucose-lowering therapy for a patient with type 2 diabetes (T2D), on metformin (biguanide) 1g twice daily (BD) and empagliflozin (SGLT2 inhibitor) 25mg daily, following a ketogenic diet, with a history of euglycemic diabetic ketoacidosis (EDKA) and recent episode of gastroenteritis, now with impaired glycemic control (HbA1c 8.7%) and seeking to avoid weight gain?
What is the appropriate evaluation and management for a patient with an elevated alanine aminotransferase (ALT) level?
What is the recommended pediatric dose of ondansetron (Zofran) for children ≥ 4 kg?
In an infant with inspiratory stridor that worsens when supine, a barky cough, and episodic cyanosis/shortness of breath, what is the appropriate initial management—reassurance and close monitoring, supraglottoplasty, or tracheostomy?
What is the prognosis for renal cell carcinoma at each stage and how do histology, grade, age, performance status, and risk models influence survival?
What is the recommended initial evaluation and management for a postmenopausal woman (≥45 years) presenting with uterine bleeding?
What is the recommended oral fluconazole regimen for an adult with uncomplicated cutaneous candidiasis who has no hepatic impairment, is not pregnant, and has no drug interactions, when topical therapy is unsuitable or has failed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.